1. The Banff 2024 Kidney Meeting Report: Rejection as a spectrum of phenotypes and focus on differential diagnostic reasoning
    2026.
    doi: 10.1016/j.ajt.2026.01.018
  2. Pathologic evaluation of pig kidney and heart xenografts: 2024 recommendations from the Banff Xenotransplantation Pathology Working Group
    2026.
    doi: 10.1016/j.ajt.2026.04.011
  3. Banff 2024 Pancreas Transplantation Report: Diagnosis and impact of chronic active T cell-mediated allograft rejection and re-evaluation of the indeterminate category with utilization of leukocyte immunostains in biopsies with ambiguous findings
    2026.
    doi: 10.1016/j.ajt.2026.04.006
  4. XVIIth Banff Conference on Allograft Pathology: The Banff Workshop heart report on microvascular inflammatory burden in heart transplantation and the impact of molecular and noninvasive diagnostic tools
    2026.
    doi: 10.1016/j.ajt.2026.04.024
  5. Banff 2022 Liver Group Meeting report: Monitoring long-term allograft health
    2024.
    doi: 10.1016/j.ajt.2024.03.008
  6. The Banff 2022 Kidney Meeting Work Plan: Data-driven refinement of the Banff Classification for renal allografts
    2023.
    doi: 10.1016/j.ajt.2023.10.031
  7. The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics
    2023.
    doi: 10.1016/j.ajt.2023.10.016
  8. Banff 2022 Vascularized Composite Allotransplantation Meeting Report: Diagnostic criteria for vascular changes
    2023.
    doi: 10.1016/j.ajt.2023.12.023
  9. The 2022 Banff Meeting Lung Report
    2023.
    doi: 10.1016/j.ajt.2023.10.022
  10. Report of the 2022 Banff Heart Concurrent: Focus on non-human leukocyte antigen antibodies in rejection and the pathology of “mixed” rejection
    2023.
    doi: 10.1016/j.ajt.2023.10.004
  11. Banff 2022 pancreas transplantation multidisciplinary report: Refinement of guidelines for T cell–mediated rejection, antibody-mediated rejection and islet pathology. Assessment of duodenal cuff biopsies and noninvasive diagnostic methods
    2023.
    doi: 10.1016/j.ajt.2023.10.011
  12. ‘Reinnovating Nephrology—a Call to Action’.
    Moghe, Ishita, Hu, Rebecca, Puja Dhungana, William H. Fissell, and Solez Kim.
    Kidney International, vol. 99, no. 1, Jan. 2021, pp. 5–8. DOI.org (Crossref), https://doi.org/10.1016/j.kint.2020.08.032.
  13. ‘Thirty Years of the International Banff Classification for Allograft Pathology: The Past, Present, and Future of Kidney Transplant Diagnostics’.
    Loupy, Alexandre, et al.
    Kidney International, Dec. 2021, p. S008525382101142X. DOI.org (Crossref), https://doi.org/10.1016/j.kint.2021.11.028.
  14. Revisiting the changes in the Banff classification for antibody-mediated rejection after kidney transplantation
    2021.
    doi: 10.1111/ajt.16474
  15. Banff Digital Pathology Working Group: Going digital in transplant pathology
    2020.
    doi: 10.1111/ajt.15850
  16. Banff survey on antibody-mediated rejection clinical practices in kidney transplantation: Diagnostic misinterpretation has potential therapeutic implications
    January 2019.
    doi: 10.1111/ajt.14979
  17. The History and Future of CyberNephrology and Relationship to the Banff Classification.
    Kim Solez, Assel Rakhmetova, Nikhil Shah, Lekhini Bhatt, Ishita Moghe, James Burdick
    Renal Replacement Therapy: controversies and future trends. 2018.
  18. The Human Cell Atlas Project by the numbers: Relationship to the Banff Classification
    Moghe I, Loupy A, Solez K.
    Am J Transplant. 2018;18:1830. DOI: 10.1111/ajt.14757
  19. A 2018 Reference Guide to the Banff Classification
    Roufosse C, Simmonds N, Clahsen-van Goningen M, Haas M, Henriksen K, Horsfield C, Loupy A, Mengel M, Perkowska-Ptasinska A, Robant M, Racusen L, Solez K, Becker J.
    Transplantation: 2018 July;18 (1)
    doi: 10.1097/TP.0000000000002366
  20. Kim Solez, Edmonton, Alberta, Canada Banff A Unique Start Setting Standards for Consensus Conferences.
    Solez K.
    Transplantation. 2017 Oct;101(10):2264-2266. doi: 10.1097/TP.0000000000001901. No abstract available.
    PMID: 28926520
  21. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.
    Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, Nankivell BJ, Halloran PF, Colvin RB, Alachkar N, Bagnasco S, Bouatou Y, Becker JU, Cornell L, Duong van Huyen JP, Gibson I, Mannon R, Naesens M, Nickeleit V, Nickerson P, Segev DL, Singh HK, Stegall M, Randhawa P, Racusen L, Solez K, Mengel M.
    Am J Transplant. 2017 Dec 15. doi: 10.1111/ajt.14625. [Epub ahead of print]
    PMID: 29243394
  22. Acceptance of Gold Medal From the Catalan Society of Transplantation by Drs. Lorraine Racusen and Kim Solez – With Remarks on the Banff Meeting Spirit
    Racusen LC, Solez K.
    Transplant Proc. 2017 Dec;49(10):2243-2246. doi: 10.1016/j.transproceed.2017.10.013.
    PMID: 29198653
  23. Lorraine Racusen and Kim Solez Awarded the Gold Medal of the Catalan Transplant Society
    Serón D, Roman A.
    Transplant Proc. 2017 Dec;49(10):2240-2242. doi: 10.1016/j.transproceed.2017.09.044.
    PMID: 29198652
  24. The bridge between transplantation and regenerative medicine: Beginning a new Banff classification of tissue engineering pathology.
    Solez K, Fung KC, Saliba KA, Sheldon VLC, Petrosyan A, Perin L, Burdick JF, Fissell WH, Demetris AJ, Cornell LD.
    Am J Transplant. 2017 Dec 1. doi: 10.1111/ajt.14610. [Epub ahead of print]
    PMID:29194964
  25. The XIIIth Banff Conference on Allograft Pathology: The Banff 2015 Heart Meeting Report: Improving Antibody-Mediated Rejection Diagnostics: Strengths, Unmet Needs, and Future Directions
    Bruneval P, Angelini A, Miller D, Potena L, Loupy A, Zeevi A, Reed EF, Dragun D, Reinsmoen N, Smith RN, West L, Tebutt S, Thum T, Haas M, Mengel M, Revelo P, Fedrigo M, Duong Van Huyen JP, Berry GJ.
    Am J Transplant. 2017 Jan;17(1):42-53. doi: 10.1111/ajt.14112. Epub 2016 Dec 12.
    PMID: 27862968
  26. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
    Loupy A, Haas M, Solez K, Racusen L, Glotz D, Seron D, Nankivell BJ, Colvin RB, Afrouzian M, Akalin E, Alachkar N, Bagnasco S, Becker JU, Cornell L, Drachenberg C, Dragun D, de Kort H, Gibson IW, Kraus ES, Lefaucheur C, Legendre C, Liapis H, Muthukumar T, Nickeleit V, Orandi B, Park W, Rabant M, Randhawa P, Reed EF, Roufosse C, Seshan SV, Sis B, Singh HK, Schinstock C, Tambur A, Zeevi A, Mengel M.
    Am J Transplant. 2017 Jan;17(1):28-41. doi: 10.1111/ajt.14107.
    PMID: 27862883
  27. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology
    Solez K, Axelsen RA, Benediktsson H et al.
    Kidney Int. 1993 Aug;44(2):411-22.
    (Recommend accessing this pdf file using Chrome or Edge browser.)

Banff meeting publications before 2016:
https://web.archive.org/web/20211204022026/https://cybernephrology.ualberta.ca/Banff/2015/MySite/Publication.html